Aston Group to enter Kazakhstan market

Publication date: 7 september 2015

Aston Group has expanded its operations to the healthcare markets of Eurasian Economic Union.

The first step was registration of LLP Aston Group Kazakhstan and setting up an office in Almaty in the summer of 2015.

According to Anton Artyomov, the СЕО of Aston Group, this move would allow the company to establish a more effective communication with numerous customers in Kazakhstan.

At the end of June 2015, following the invitation by the President of AIPM Kazakhstan, V.N. Lokshin, Aston team made a presentation at the Association's meeting. Members of the Association (representatives of global pharmaceutical companies) expressed their interest in using the capabilities of our Clinical Patient Registries, and Patient Support Programs (PSP).

 

Anton Artyomov pointed to the fact that the profound expertise and market knowledge of Aston Group helps bring together the industry stakeholders and boost communication between them, which is especially important in today's economic environment:

‘No doubt, that the projects we’ve been implementing related to lab diagnostics, patent support programs and pharmacoeconomic analysis contribute to increased involvement of global pharmaceutical companies in the emerging health markets. This is a global trend that includes Russia and other EEU countries.’